Pharma/Biotech – USA, Europe and Asia Regulatory Updates Roundup – Sept 2024
USA
FDA Clears First-in-Class Non-Opioid Treatment...
5 Key Reasons Why Regulatory Publishing Services Are Essential for Biopharma Companies
In today’s highly regulated biopharmaceutical indu...
BioPharma – USA/UK/Asia Regulatory Updates, Aug 2024
USA
FDA Approves First Nasal Spray for Treatment o...
BioPharma – USA/Europe/Asia Regulatory Updates, July 2024
USA The FDA approved Femlyv (norethindrone acetate...
BioPharma – USA/Europe/Asia Regulatory Updates, June 2024
USA
FDA Permits Marketing of First Point-of-Care H...
BioPharma – USA/Europe/Asia Regulatory Updates, April 2024
USA Content and Format of Composition Statements i...




